Follow this and additional works at: https://uknowledge.uky.edu/crvaw_facpub Results: Fourteen analytical and twelve experimental studies that met our criteria were reviewed. Lesion severity and health beliefs were consistently associated with adherence rates. Communication interventions, including telephone reminders, counseling, and educational sessions, increased follow-up compliance across intervention studies. Inconsistent evidence for associations among race, income, and age were found.
INTRODUCTION W
HEN CERVICAL CANCER IS DETECTED EARLY, the likelihood of survival is almost 100% with appropriate follow-up and treatment. 1 Despite the preventable and treatable nature of this cancer, the American Cancer Society (ACS) estimates that almost 4000 women will have died from cervical cancer in 2006 in the United States. 2 A key part of this discrepancy is failure to obtain follow-up care after an abnormal Pap test. The Pap test, which screens for precursor lesions to cervical cancer, is one of the most used cancer screening tools currently available; countrywide estimates from the Behavioral Risk Factor Surveillance System (BRFSS) in 2004 report that 78%-90% of women aged Ͼ18 years had a Pap test within the preceding 3 years. 3 Follow-up diagnostic examinations and, if necessary, treatment are central to the effectiveness of the Pap test in the prevention of invasive cervical cancer. 4 In a recent study of long-term members of a comprehensive medical care program, 13% of invasive cervical carcinomas were attributable to failure to follow up with abnormal Pap test results. 5 With the majority of women adhering to Pap test guidelines, more research is needed to determine why women who receive an abnormal result are not complying with necessary follow-up and treatment schedules.
A large body of literature suggests multiple factors are associated with adherence to followup recommendations, including factors associated with the patient, both demographic and psychosocial in nature, and with the healthcare system. [6] [7] [8] [9] The purpose of this systematic review is to summarize reports from recent analytical or experimental research that addressed factors associated with the lack of adequate and timely follow-up care for an abnormal Pap test (nonadherence). The future aim is to facilitate both patient and clinic-based interventions to improve adherence to follow-up recommendations and, thus, reduce needless deaths due to cervical cancer. This is the first review to include both analytical and intervention studies addressing adherence to abnormal Pap test follow-up recommendations and to address risk factors for lack of follow-up by individual, psychosocial, and attributes of the healthcare system.
MATERIALS AND METHODS
A systematic approach to all literature was used to identify original research addressing follow-up of an abnormal Pap test. Our review included academic peer-reviewed sources from the following databases: Medline, Pubmed, Science Direct, Medline-Ovid, Med Science, and EbscoMedline. The search terms used were: abnormal Pap, colposcopy, Pap test, screening, gynecologist, or cervical cancer, adherence, follow-up, barriers. Reference lists from papers identified were also reviewed for inclusion of additional papers.
To develop a comprehensive review, we included papers published from 1990 to 2005 regardless of whether they had been included in past reviews. The outcome of interest for all papers reviewed was adherence to recommended follow-up care for an abnormal Pap test. In addition, all papers included in the review had to address risk factors for adherence or involve interventions to improve adherence. A total of 73 abstracts were originally identified. Table 1 outlines the criteria for inclusion in this systematic review and the numbers excluded based on these criteria. We required that each study be evidence based, in that the research involved following women either prospectively or retrospectively through follow-up care after an abnormal Pap test (11 excluded). Studies conducted outside the United States were excluded because different systems of medical care are not comparable to that of the United States (n ϭ 12). Papers not published in English were also excluded (n ϭ 7). Finally, qualitative research (n ϭ 4), recent reviews (n ϭ 5), and literature older than 1990 (n ϭ 8) were also excluded from this review. 
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Defining abnormal Pap tests
For the purposes of this review, an abnormal Pap test includes any result that requires additional diagnostic or follow-up procedures. Therefore, the following Pap test results were considered abnormal: insufficient Pap test, infection, atypia, atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesion (HSIL), and atypical glandular cells (AGC).
Defining adherence
In this review, definitions of adherence varied across studies, but all were evaluated based on follow-up after an abnormal Pap test result within a time period specified by each healthcare office or governing organization.
RESULTS
Twenty-six papers were identified that met our criteria. All studies were quantitative, defined here as a study analyzing data using statistics that reported a p value for correlations and predictors. Table 2 summarizes the key design elements of the 26 quantitative papers that addressed adherence for abnormal Pap test follow-up. The studies are arranged alphabetically by the first author's last name and are presented in two groups by the study design (analytical and experimental studies). Fourteen papers used an analytical study design and addressed risk factors for adherence. [10] [11] [12] [13] [14] [18] [19] [20] 23, [27] [28] [29] 31, 34 Twelve studies used an experimental or quasiexperimental design: 9 were randomized trials 16, 17, [24] [25] [26] 30, 32, 33, 35 and 3 were intervention studies based on nonrandomized designs. 15, 21, 22 Table 2 provides the study setting and sample, the number of subjects, the data source and list of independent variables assessed, and the data source and operational definition of the outcome (adherence to follow-up recommendations for an abnormal Pap test).
Study sites included public health and community clinics, 11, 14, 18, 19, [27] [28] [29] hospitals, 13,31 academic clinics, 12, 23, 34 the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), 10 and a large consortium of laboratories. 20 The sample sizes ranged from 119 23 to 16,132 women. 20 With the exception of four studies that relied on self-report through telephone interviews and questionnaires, 15, 27, 30, 31 all used medical records to obtain data on independent variables. All studies addressed demographic factors as independent variables correlated with adherence; among these were age, race/ethnicity, insurance, marital status, education, income, place of residence, primary language spoken, tobacco use, and cervical lesion severity.
The reviewed research used medical records or self-report to determine adherence and defined adherence as the receipt of recommended followup care. However, studies differed in the definition of adherence. Most studies used a restricted time frame [10] [11] [12] 15, 16, 18, 20, 21, 23, 26, [28] [29] [30] 34, 35 that ranged from receipt of follow-up care within 4-6 weeks 35 to receipt of follow up care within 18 months. 16 Other studies measured adherence by the number of follow-up appointments kept, 14 ever completing the recommended procedure, 19, 22, 24, 25, 27, 31 or adherence within the time frame set by the physician. 32, 33 Table 3 lists the measures of association, a summary of the study findings, and adherence rates. Adherence rates for the analytical studies ranged from 27% 28 to 90%, 19 whereas those of the experimental studies ranged from 40% 21 to 93% 15 for those receiving the intervention. Nine of twelve intervention studies [15] [16] [17] [24] [25] [26] 30, 32, 35 reported higher adherence among those participating in the intervention. The findings are summarized by patient, healthcare system, and social/ environmental characteristics.
Patient characteristics
Age. Of the 14 studies 10, 11, 14, [16] [17] [18] 20, [23] [24] [25] [26] [27] 31, 34 that addressed age and adherence, 7 found that younger women were less likely to receive follow-up care. 16, 17, 20, [25] [26] [27] 34 Specifically, McKee et al. 27 reported that teenagers and women older than 30 were less likely to receive follow-up care. Additionally, a study conducted by Fox et al. 18 reported that increased age was a significant risk factor for noncompliance.
Race/ethnicity. Of the 10 analytical [10] [11] [12] 14, 18, 23, 27, 28, 31, 34 and 7 experimental 16, 17, [24] [25] [26] 30, 32 studies to address race/ethnicity and adherence, 7 10, 11, 17, 18, 25, 26, 32 found that African American women were less likely to schedule follow-up visits, to keep appointments, or to receive follow-up care. Specifically, Cardin et al. 11 reported that African American women with ASCUS/LSIL were less likely to be compliant than African American women with HSIL. Four studies 12, [16] [17] [18] reported that Asian women were less likely than women of other race/ethnicities (whites or African Americans) to comply with follow-up recommendations. Finally, two studies found that Hispanics were significantly less likely to adhere to follow-up recommendations than white 18 and African American women. 25 However, the only study to address fatalism and health beliefs, 31 reported that race/ ethnicity was no longer associated with adherence after adjusting for these factors.
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Primary language. All three studies that investigated a primary language other than English as a barrier to follow-up care 17, 29, 34 concluded that this demographic was not associated with adherence.
Place of residence.
Two studies examined place of residence by assessing urban vs. rural residence 18 and proximity to clinic. 29 Proximity to clinic was not a predictor of adherence, 29 but urban setting was a significant predictor of nonadherence. 18 Education. Five studies investigated educational attainment, measured by receipt of a high school diploma, 24, 25, 27, 30, 31 as a predictor of adherence to follow-up care. Only one study found that those with less than a high school education were less likely to return for follow-up care. 25 Pregnancy status. Three studies addressed pregnancy status and adherence 17, 20, 28 ; only and Novis 20 reported that pregnant women were less likely to receive timely follow-up. Gravidity and parity were not associated with adherence in one study, 14 although being nulliparous was positively associated with being adherent in another. 32 Tobacco use. Two studies that assessed tobacco use as a predictor of adherence to follow-up found conflicting results. Eger and Peipert 14 found that tobacco use was not associated with the number of follow-up appointments kept, whereas, Paskett et al. 32 found that nonsmokers were more likely than smokers to follow up within 1 week of the date specified by the physician.
Income/insurance/cost of follow-up. Thirteen studies addressed income, 14, 19, 31 insurance, 14, 16, 17, 23, [25] [26] [27] [28] [29] 34 or cost as barriers to receiving follow-up care. 21, 25, 26 Four found that those with higher income 19 or private insurance 25, 29, 34 were more likely to adhere to recommended follow-up. Conversely, Engelstad et al. 16 found that women with no insurance were more likely to have a followup visit in 6 months than those with insurance. The remaining eight studies found no association between adherence and income 14, 21, 31 or insurance. 14, 17, 23, [26] [27] [28] Of three interventions 21, 25, 26 to address economic strain, however, two reported that transportation incentives 25 and economic vouchers had a significant impact on adherence. 26 Furthermore, cost, transportation, and child care problems were among the most frequent barriers reported by others. 15, 24, 30 Knowledge of Pap test. Several studies addressed the influence of Pap test knowledge on adherence to follow-up. 13, 15, 17, [24] [25] [26] [30] [31] [32] [33] Both Crane 13 and Nelson et al. 31 found that women who did not know the purpose of a Pap test were less likely to adhere to recommendations than those who correctly identified the purpose. Two studies that investigated barriers to care reported that lack of understanding of the purpose of a follow-up examination was a reason for nonadherence. 15, 24 Studies that used educational brochures 26, 32, 33 or a tape on Pap tests 25 all reported a significant increase in compliance. Telephone counseling interventions, including education on abnormal Pap tests and the importance of follow-up, also predicted adherence. 15, 17, 24, 30 Finally, Lavin et al. 23 found that a visit to an adolescent clinic positively predicted adherence; the authors speculated that during this visit, more information on the purpose and importance of follow-up care may have been given.
Lesion severity. Of the 15 studies that addressed lesion severity and adherence, 10, 11, 14, [16] [17] [18] 20, 23, [25] [26] [27] [28] [29] 32, 34 11 10, 11, 14, [16] [17] [18] 20, 25, 26, 28, 29, 32 found that women with less severe lesions were less likely to adhere to followup recommendations. Melnikow et al. 29 reported that, overall, women with LSIL/HSIL were more likely to adhere to any appointment compared with women with ASCUS; however, women with LSIL/HSIL were less likely to adhere to colposcopy compared with repeat Pap tests, whereas women with ASCUS were more likely to adhere to colposcopy compared with repeat Pap tests. When following women after two abnormal Pap tests, Benard et al. 10 stated that women whose results were less severe on the second assessment were least likely to receive the recommended colposcopy.
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Psychosocial factors Psychological barriers. When addressing health beliefs and adherence, Nelson et al. 31 found that fatalism and health beliefs (specifically, that Pap tests were needed only when one had abnormal bleeding) were associated with poor adherence. Another study addressed psychological factors, including fear of cancer, embarrassment of pelvic examinations, and belief in early detection and follow-up. Researchers reported no significant differences in adherence among women who differed in responses on these items. 27 Four intervention studies used a case management approach to address psychosocial factors, including attitudes, coping skills, anxiety, and fear resulting from an abnormal Pap test result. 15, 17, 24, 30 Psychological barriers to care reported by women in each study included fear of finding cancer, worries about examination/treatment, and fertility concerns. All interventions addressing these concerns resulted in significant differences in adherence; women in the intervention group in each respective study were more than twice as likely to follow up as women in the control group. 15, 17, 24, 30 Social support. Six studies addressed social support and marital status or live-in relationship as a predictor of adherence to follow-up after an abnormal Pap test. 13, 14, [24] [25] [26] 30 Two found that women with a live-in relationship 26 or those with any type of social support 13 were more likely to follow up within 4-6 months than those without a live-in relationship or any kind of social support. Crane. 13 found that the type of support most likely to affect adherence differed by ethnic group. African American women were more likely to adhere when emotional support was available, whereas tangible support significantly influenced adherence among Latinas. 13 Healthcare system characteristics A number of studies assessed the relationship of adherence to existing clinician and site characteristics, including appointment reminder protocols. [15] [16] [17] [19] [20] [21] [22] [26] [27] [28] 30, 34, 35 Patient involvement/communication. Clinician involvement of patients in decisions, referrals, and management options were assessed in two studies. 19, 28 Hartz and Fenaughty 19 reported that patients who chose surveillance had improved initial adherence but not long-term adherence. McKee et al. 28 reported that discussion of followup options and plans at a prior visit increased adherence rates. Communication between clinicians and patients was also noted as a factor influencing adherence to follow-up. Lack of effective communication was associated with lower rates of adherence in one study, 27 as both "knowledge of results" and "getting the doctor to understand my needs" were significantly associated with adherence in univariate analysis.
Healthcare facility/clinician specialty. Site attributes were also assessed as an indicator of adherence to follow-up in some studies. McKee et al. 28 reported that clinics with colposcopy on-site had higher adherence rates. Takacs et al. 35 reported that patients randomized to the video colposcopy were five times more likely to return for followup care relative to those receiving traditional colposcopy. Lacey et al. 22 reported no difference in follow-up rates between women who were referred to the public hospital and those who chose to follow up with their private physician. Furthermore, three studies 27, 28, 34 found that clinician specialty was not associated with improved adherence. The only study to address laboratory characteristics 20 reported no association between adherence and the type of follow-up system used by clinics, laboratory reporting summaries, or the proficiency of cytologists in reading slides.
Reminder protocols. Several experimental studies included protocols in which the healthcare facility called or sent a reminder letter approximately 1 week before the woman's appointment for follow-up care. [15] [16] [17] 21, 26, 30 Five [15] [16] [17] 26, 30 of six studies reported a positive association between the reminder protocol and adherence to followup care; three of the studies were coupled with telephone counseling or an educational pamphlet. 15, 17, 26 Miller et al. 30 reported that the telephone reminder system was effective at increasing adherence rates, but not as effective as additional telephone counseling. The only study to report no change in adherence used a letter instead of a telephone reminder system. 21 Table 4 outlines the strength and quality of studies reviewed and provides a corresponding score based on the following categories: power/ sample size, use of a theoretical model, study design, response rate, outcome validation, and measurement of lesion severity. Studies that used a retrospective cohort design were not considered when assessing response rates. [10] [11] [12] 14, 18, 20, 23, 28, 29, 34 Therefore, the total score was out of 14 points for those with a response rate and 12 points for those without a response rate. Studies that scored within the top third of the sample were determined to be of high quality (score Ն 0.67) (Table  4) . 10, 11, 17, 18, 20, 21, 25, 26, [30] [31] [32] Sample size indicates study power and the ability to correctly rule out the possibility that a type 2 error occurred (not having sufficient power to detect a true association). Study power is, however, a function of sample size, the prevalence of the independent variable, and the prevalence of the outcome in the study population. Among the reviewed research, nine had good study power. 10, 11, 18, 20, 21, 25, 26, 30, 31 The randomized trial design was a strength for nine studies. 16, 17, [24] [25] [26] 30, 32, 33, 35 Eleven studies used a theoretical model to guide their research, which was considered a strength. 13, 15, 17, 21, 22, 25, 27, [30] [31] [32] [33] Only one study reported a low response rate (35%), 15 which may indicate questionable validity of the study results.
Strengths and limitations of reviewed research
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Misclassification of both the independent and outcome variables can be a concern for observational studies and may lead to information bias. Studies that relied exclusively on medical records for information on patient characteristics [10] [11] [12] 14, 16, [18] [19] [20] [21] [22] [23] [24] [25] [28] [29] [30] [31] [32] [33] [34] [35] may have misclassified these variables if they are not routinely available in medical records. Further, women who received follow-up care at other clinics may have been misidentified as nonadherent if self-reported follow-up was not available. Four studies obtained adherence information through self-report in addition to medical record abstraction; these studies both validated their outcomes using another source and were able to obtain complete documentation from other sites. 13, 15, 26, 27 Another study 17 excluded women who reported followup at another clinic to avoid this bias.
Because lesion severity may directly impact the importance of and timeliness of adherence, we included assessment by lesion severity as a component of quality. Fourteen of 26 studies either conducted separate analysis by lesion severity or included only one type of lesion in their research. 10, 11, [15] [16] [17] [18] [19] [20] [21] 25, 26, 28, 29, 32 As previously noted, having a range of adherence definitions makes comparisons across the studies challenging. In general, those studies with shorter time intervals for defining adherence may be more prone to outcome misclassification. However, different types of noncompliance exist (e.g., delay in seeking care, nonparticipation in care, and cancellation of appointments), so all may be considered an appropriate measure. Table 5 provides a summary of factors addressed by the literature included in this systematic review. Table 5 Table 5 indicates the number of high-quality studies that contributed to the results.
Summary of reviewed research
DISCUSSION
Over the past 15 years, many factors have been hypothesized to affect adherence to follow-up procedures following an abnormal Pap test. In this discussion, we focus on modifiable risk factors for adherence at the patient, psychosocial, and healthcare system levels and address future directions for research.
Patient factors
Among those modifiable factors associated with the patient, the majority of studies included in this review agreed that women with less severe lesions were less likely to be adherent to follow-up care. 10, 11, 14, 16, 18, 20, 25, 26, 28, 29, 32 Reasons for this association may include a belief of both women and clinicians that follow-up is less important for less severe Pap test results. Although this may in general be true, all women recommended for follow-up should receive follow-up care in a timely manner, as some less severe lesions may become more severe without follow-up. Potential interventions may include stressing the importance of follow-up regardless of lesion severity during patient-provider meetings and within educational materials addressing abnormal Pap tests.
The Pap test can detect lesions that will never progress to cervical cancer; therefore, women Quality of study defined by: power/sample size, use of theoretical model, study design, response rate, outcome misclassification, and separation of lesion severity in analysis (Table 4 ).
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*p Յ 0.001; no measure of strength or point estimate was reported in the study.
who have an abnormal Pap test result of ASCUS are now routinely tested for human papillomavirus (HPV). Because most cervical cancer cases result from persistent HPV infection, proper education and counseling of the potential impact of a positive HPV result may motivate women to adhere to follow-up care in a timely manner. Many women have noted lack of time, money, or insurance as barriers to receiving timely follow-up care. 8, 15 Although the majority of studies found no association between economic factors and adherence, 14, 17, 21, 23, [26] [27] [28] 31 transportation incentives and economic vouchers did significantly increase adherence. 25, 26 Currently, the Breast and Cervical Cancer Treatment Act provides medical assistance through Medicaid to eligible women who were screened for and found to have breast or cervical cancer, including precancerous conditions. However, women who are ineligible for this service still may feel they cannot afford follow-up care; these women may benefit from targeted interventions to address economic barriers to follow-up care.
Misunderstanding of the purpose of a Pap test and the need for follow-up after an abnormal result were frequent barriers to care. 13, 15, 24, 31 All interventions that addressed knowledge of the Pap test and cervical cancer significantly increased adherence rates. 15, 17, [24] [25] [26] 30, 32, 33 The current knowledge gap can be addressed on a personal level by nurses, community health workers, and patient navigators tailoring informational needs to each woman. Furthermore, a need clearly exists for a comprehensive, easy to understand, and culturally acceptable brochure to aid in the education of women who have an abnormal Pap test.
Psychosocial factors
Social factors, such as the ability to cope effectively with an abnormal result, 30 as well as other attitudinal beliefs that may be influenced by social support 36 or culture may be important and potentially modifiable risk factors for nonadherence. To illustrate, greater fatalism was associated with lower adherence rates in two studies reviewed; 15, 31 further, fatalism appears to be a mediator in the association between race and adherence and, unlike race, is potentially modifiable. 31 The literature supports that the emotional reaction (e.g., fear, anxiety, and depression) to the news of an abnormal Pap test result may reduce a woman's ability to return for follow-up care in a timely manner. 8, 15, 17, 24, 30, 31, [37] [38] [39] A small literature suggests that stressful events occurring in women's lives around the time of the abnormal Pap test may serve as competing life priorities, thereby reducing the likelihood of obtaining follow-up care. [40] [41] [42] Effective coping strategies to reduce psychological distress from an abnormal Pap result have been noted. 13, 43 In order to reduce clinic no-show rates, we need a better understanding of the interactions among anxiety, distress, effective coping, and support as they affect adherence.
Healthcare system characteristics
Although patients are ultimately responsible for following the recommendations of their clinicians, clear patient-provider or laboratory communications may have a positive impact on adherence. Enhanced communication between the patient and the provider in experimental studies included in this review resulted in increased adherence rates. 16, 17, 24, 25, 30, 32, 33 Interventions aimed at reducing this communication barrier included telephone reminder systems, counseling/educational sessions, and instructive and culturally relevant pamphlets. The success of these interventions is consistent with studies reviewed by Yabroff et al. 4 and Abercrobmie. 7 These interventions may differentially affect women across a range of socioeconomic levels, and were tailored to meet women's individual needs.
Little research has addressed individual characteristics of the provider in influencing the effectiveness of communication. Future directions for research could include elements of effective patient-provider communication. These may include observational studies with permissible videotaped interactions. The type of healthcare provider may vary (e.g., physician, nurse, health education counselor), but the ability of the provider to simply and effectively communicate medical information as well as personal concern for that patient would be an important contribution.
CONCLUSIONS
Inconsistent evidence for risk factors and barriers to receipt of follow-up care as well as extreme differences in reported adherence rates
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across the 26 scholarly papers reviewed indicate that the influence of demographic, individual, and healthcare system level factors on adherence to abnormal Pap tests is undoubtedly complex. Women differ in their knowledge of cervical cancer screening, their attitudes toward preventive follow-up care, and their overall access to this care, including financial and transportation barriers. Similarly, healthcare providers differ in their attitudes and communication skills. The healthcare system may determine follow-up availability on site and extended clinic hours.
Future directions
A range of barriers for adherence to follow-up after an abnormal Pap test have been identified in the existing literature. Therefore, the most cost-effective strategy to overcome diverse barriers among at-risk populations will likely include tailored interventions through case management or patient navigation. Additionally, although many modalities of patient education are used (e.g., letter, pamphlets, videotape/DVD, phone calls, emails, websites), little research has addressed the content of the material in terms of the intended audience, the cultural competence for a range of audiences, or the accuracy in light of new HPV testing methods, screening, and follow-up options.
Successful interventions, if incorporated into everyday practice, may increase the short-term cost of healthcare services. A recent study by Wagner et al. 44 however, suggests that tailored counseling interventions may be more cost-effective than usual care among high-risk populations. 44 By reducing barriers to follow-up care for abnormal Pap tests, the financial cost of late-stage treatment for cervical cancer will decrease. Further, decreases in the adverse physical, psychological, and emotional effects of cervical cancer morbidity and mortality would be significant.
